Percutaneous techniques for treatment of tricuspid valve dysfunction in congenital heart disease – an emerging therapy

References

• Ebstein W. Ueber einen sehr seltenen Fall von Insufficienz der Valvula tricuspidalis bedingt durch eine angeborene hochgradige Missbildung derselben. Arch Anat Physiol. 1866;33:238–255.
   Google Scholar
• Schreiber C, Cook A, Ho SY, et al. Morphologic spectrum of Ebstein’s malformation: revisitation relative to surgical repair. J Thorac Cardiovasc Surg. 1999;117:148–155.
   PubMed Web of Science ®Google Scholar
• Pflaumer A, Eicken A, Augustin N, et al. Symptomatic neonates with Ebstein anomaly. J Thorac Cardiovasc Surg. 2004;127:1208–1209.
   PubMed Web of Science ®Google Scholar
• Attie F, Rosas M, Rijlaarsdam M, et al. The adult patient with Ebstein anomaly. Outcome in 72 unoperated patients. Medicine (Baltimore). 2000;79:27–36.
   PubMed Web of Science ®Google Scholar
• Brown ML, Dearani JA, Danielson GK, et al. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg. 2008;135:1120–1136,1136.e1-7.
   Web of Science ®Google Scholar
• Baumgartner H, De Backer J, Babu-Narayan SV, et al. ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2020;ehaa554.
   PubMedGoogle Scholar
• Scherptong Roderick WC, Vliegen Hubert W, Winter Michiel M, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle. Circulation. 2009;119:1467–1472.
   PubMed Web of Science ®Google Scholar
• Burri M, Vogt MO, Hörer J, et al. Durability of bioprostheses for the tricuspid valve in patients with congenital heart disease. Eur J Cardiothorac Surg. 2016;50:988–993.
   PubMed Web of Science ®Google Scholar
• Eicken A, Kasel M, Ewert P. Failing bioprosthesis in systemic tricuspid position after a Senning procedure – successful percutaneous tricuspid valve implantation. Catheter Cardiovasc Interv. 2017;89:E137–E140.
   PubMed Web of Science ®Google Scholar
• Hardy KL, May IA, Webster CA, et al. Ebstein's anomaly: a functional concept and successful definitive repair. J Thorac Cardiovasc Surg. 1964;48:927–940.
   PubMed Web of Science ®Google Scholar
• Barnard CN, Schrire V. Surgical correction of Ebstein’s malformation with prosthetic tricuspid valve. Surgery. 1963;54:302–308.
   PubMed Web of Science ®Google Scholar
• Danielson GK, Fuster V. Surgical repair of Ebstein’s anomaly. Ann Surg. 1982;196:499–504.
   PubMed Web of Science ®Google Scholar
• Carpentier A, Chauvaud S, Macé L, et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96:92–101.
   PubMed Web of Science ®Google Scholar
• da Silva JP, Baumgratz JF, da Fonseca L, et al. The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215–223.
   PubMed Web of Science ®Google Scholar
• Burri M, Agua KM, Cleuziou J, et al. Cone versus conventional repair for Ebstein’s anomaly. J Thorac Cardiovasc Surg [Internet]. 2020 [cited 2020 Sep 22];160:1545–1553.
   PubMed Web of Science ®Google Scholar
• Guenther T, Noebauer C, Mazzitelli D, et al. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2008;34: 402–409. discussion 409.
   PubMed Web of Science ®Google Scholar
• Filsoufi F, Anyanwu AC, Salzberg SP, et al. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg. 2005;80:845–850.
   PubMed Web of Science ®Google Scholar
• Kaplan M, Kut MS, Demirtas MM, et al. Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical. Ann Thorac Surg. 2002;73:467–473.
   PubMed Web of Science ®Google Scholar
• Rizzoli G, Vendramin I, Nesseris G, et al. Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg. 2004;77:1607–1614.
   PubMed Web of Science ®Google Scholar
• Chang B-C, Lim S-H, Yi G, et al. Long-term clinical results of tricuspid valve replacement. Ann Thorac Surg. 2006;81:1317–1324.
   PubMed Web of Science ®Google Scholar
• Garatti A, Nano G, Bruschi G, et al. Twenty-five year outcomes of tricuspid valve replacement comparing mechanical and biologic prostheses. Ann Thorac Surg. 2012;93:1146–1153.
   PubMed Web of Science ®Google Scholar
• Marquis-Gravel G, Bouchard D, Perrault LP, et al. Retrospective cohort analysis of 926 tricuspid valve surgeries: clinical and hemodynamic outcomes with propensity score analysis. Am Heart J. 2012;163(851–858.e1):851–858.e1.
   PubMedGoogle Scholar
• Jeganathan R, Armstrong S, Al-Alao B, et al. The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg. 2013;95:119–124.
   PubMed Web of Science ®Google Scholar
• Hwang HY, Kim K-H, Kim K-B, et al. Reoperations after tricuspid valve repair: re-repair versus replacement. J Thorac Dis. 2016;8:133–139.
   PubMed Web of Science ®Google Scholar
• McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127:674–685.
   PubMed Web of Science ®Google Scholar
• Raikhelkar J, Lin H-M, Neckman D, et al. Isolated tricuspid valve surgery: predictors of adverse outcome and survival. Heart Lung Circ. 2013;22:211–220.
   PubMed Web of Science ®Google Scholar
• Umehara N, Miyata H, Motomura N, et al. Surgical results of reoperative tricuspid surgery: analysis from the Japan Cardiovascular Surgery Database†. Interact Cardiovasc Thorac Surg. 2014;19:82–87.
   PubMed Web of Science ®Google Scholar
• Eicken A, Ewert P. Percutaneous tricuspid valve implantation in failing bioprosthesis. Cardiovasc Diagn Ther. 2018;8:765–770.
   PubMed Web of Science ®Google Scholar
• Tanous D, Nadeem SN, Mason X, et al. Creation of a functional tricuspid valve: novel use of percutaneously implanted valve in right atrial to right ventricular conduit in a patient with tricuspid atresia. Int J Cardiol. 2010;144:e8–e10.
   PubMed Web of Science ®Google Scholar
• Roberts PA, Boudjemline Y, Cheatham JP, et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol. 2011;58:117–122.
   PubMed Web of Science ®Google Scholar
• Eicken A, Fratz S, Hager A, et al. Transcutaneous Melody valve implantation in “tricuspid position” after a Fontan Björk (RA-RV homograft) operation results in biventricular circulation. Int J Cardiol. 2010;142:e45–47.
   PubMed Web of Science ®Google Scholar
• Godart F, Baruteau A-E, Petit J, et al. Transcatheter tricuspid valve implantation: a multicentre French study. Arch Cardiovasc Dis. 2014;107:583–591.
   PubMed Web of Science ®Google Scholar
• Andreas E, Stephan S, Alfred H, et al. Percutaneous tricuspid valve implantation. Circ Cardiovasc Interv. 2015;8:e002155.
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation. 2016;133:1582–1593.
   PubMed Web of Science ®Google Scholar
• Shah AH, Horlick EM, Eicken A, et al. Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Björk–Fontan procedure. Catheter Cardiovasc Interv. 2017;89:298–305.
   PubMed Web of Science ®Google Scholar
• Taggart NW, Cabalka AK, Eicken A, et al. Outcomes of transcatheter tricuspid valve-in-valve implantation in patients with Ebstein anomaly. Am J Cardiol. 2018;121:262–268.
   PubMed Web of Science ®Google Scholar
• Cullen MW, Cabalka AK, Alli OO, et al. Transvenous, antegrade melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc Interv. 2013;6:598–605.
   PubMed Web of Science ®Google Scholar
• Stanimir G, Peter E, Andreas E, et al. Munich comparative study. Circ Cardiovasc Interv. 2020;13:e008963.
   PubMedGoogle Scholar
• Tanase D, Grohmann J, Schubert S, et al. Cracking the ring of Edwards perimount bioprosthesis with ultrahigh pressure balloons prior to transcatheter valve in valve implantation. Int J Cardiol. 2014;176:1048–1049.
   PubMed Web of Science ®Google Scholar
• Bentham J, Qureshi S, Eicken A, et al. Early percutaneous valve failure within bioprosthetic tricuspid tissue valve replacements. Catheter Cardiovasc Interv. 2013;82:428–435.
   PubMed Web of Science ®Google Scholar
• Anderson JH, McElhinney DB, Aboulhosn J, et al. Management and outcomes of transvenous pacing leads in patients undergoing transcatheter tricuspid valve replacement. JACC Cardiovasc Interv. 2020;13:2012–2020.
   PubMed Web of Science ®Google Scholar
• Cesna S, De Backer O, Søndergaard L. Rapid adoption of transcatheter aortic valve replacement in intermediate- and high-risk patients to treat severe aortic valve stenosis. J Thorac Dis. 2017;9:1432–1436.
   PubMed Web of Science ®Google Scholar
• Dvir D First look at long-term durability of transcatheter heart valves: assessment of valve function up to 10-years after implantation [Internet]. TCTMD. [ cited 2020 Aug 24]. Available from: https://www.crtonline.org/presentation-detail/first-look-at-long-term-durability-of-transcathete.
   Google Scholar
• Prendergast B, Tamburino C, Piazza N, et al. Durability of transcatheter heart valves – much ado about nothing. EuroIntervention. 2016;12:819–820.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation [Internet]. 2017 [cited 2020 Nov 27];135. Available from::
   Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–2791.
   Google Scholar
• Sumski CA, Bartz P, Gudausky T. Percutaneous melody valve implantation in a native tricuspid valve following failed surgical repair. Catheter Cardiovasc Interv. 2018;92:1334–1337.
   PubMed Web of Science ®Google Scholar
• Kefer J, Sluysmans T, Vanoverschelde J-L. Transcatheter Sapien valve implantation in a native tricuspid valve after failed surgical repair. Catheter Cardiovasc Interv. 2014;83:841–845.
   PubMed Web of Science ®Google Scholar
• Aboulhosn J, Cabalka AK, Levi DS, et al. Transcatheter valve-in-ring implantation for the treatment of residual or recurrent tricuspid valve dysfunction after prior surgical repair. JACC Cardiovasc Interv. 2017;10:53–63.
   PubMed Web of Science ®Google Scholar
• Boudjemline Y, Agnoletti G, Bonnet D, et al. Steps toward the percutaneous replacement of atrioventricular valves: an experimental study. J Am Coll Cardiol. 2005;46:360–365.
   PubMed Web of Science ®Google Scholar
• Bai Y, Zong G-J, Wang H-R, et al. An integrated pericardial valved stent special for percutaneous tricuspid implantation: an animal feasibility study. J Surg Res. 2010;160:215–221.
   PubMed Web of Science ®Google Scholar
• Navia JL, Kapadia S, Elgharably H, et al. Transcatheter tricuspid valve implantation of navigate bioprosthesis in a preclinical model. JACC Basic Transl Sci. 2018;3:67–79.
   PubMedGoogle Scholar
• Navia JL, Kapadia S, Elgharably H, et al. First-in-human implantations of the navigate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid annuloplasty ring. Circ Cardiovasc Interv. 2017;10. DOI:https://doi.org/10.1161/CIRCINTERVENTIONS.117.005840
   Google Scholar
• Overtchouk P, Piazza N, Granada J, et al. Advances in transcatheter mitral and tricuspid therapies. BMC Cardiovasc Disord [Internet]. 2020 [cited 2020 Aug 24];20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945613/
   PubMed Web of Science ®Google Scholar
• Demir OM, Regazzoli D, Mangieri A, et al. Transcatheter tricuspid valve replacement: principles and design. Front Cardiovasc Med [Internet]. 2018 [cited 2020 Aug 20];5. Available from::
   PubMed Web of Science ®Google Scholar
• Lauten A, Figulla HR, Unbehaun A, et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv [Internet]. 2018 [cited 2020 Aug 20];11. Available from::
   Web of Science ®Google Scholar
• Vassileva CM, Shabosky J, Boley T, et al. Tricuspid valve surgery: the past 10 years from the nationwide inpatient sample (NIS) database. J Thorac Cardiovasc Surg. 2012;143:1043–1049.
   PubMed Web of Science ®Google Scholar
• Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61:1759–1766.
   PubMed Web of Science ®Google Scholar
• Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312:162–170.
   PubMed Web of Science ®Google Scholar
• Gillespie Matthew J, Rome Jonathan J, Levi Daniel S, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position. Circ Cardiovasc Interv. 2012;5:862–870.
   PubMed Web of Science ®Google Scholar
• Milburn K, Bapat V, Thomas M. Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature. Clin Res Cardiol Off J Ger Card Soc. 2014;103:417–429.
   PubMed Web of Science ®Google Scholar
• Latib A, Mangieri A, Taggart NW, et al. Transcatheter tricuspid valve repair: new valve, new opportunities, new challenges. J Am Coll Cardiol. 2017;69:1807–1810.
   PubMed Web of Science ®Google Scholar